Skip to main content

Dexamethasone Sodium Phosphate Injection Shortage

Last Updated: April 23, 2024
Status: Current

Products Affected - Description
    • Dexamethasone Sodium Phosphate injection, Eugia US, 10 mg/mL, 1 mL preservative-free vial, 25 count, NDC 55150-0304-25
    • Dexamethasone Sodium Phosphate injection, Eugia US, 10 mg/mL, 10 mL vial, 10 count, NDC 55150-0305-10
    • Dexamethasone Sodium Phosphate injection, Eugia US, 4 mg/mL, 30 mL vial, 25 count, NDC 55150-0239-30
    • Dexamethasone Sodium Phosphate injection, Fresenius Kabi, 10 mg/mL, 10 mL multiple dose vial, 10 count, NDC 63323-0516-10
    • Dexamethasone Sodium Phosphate injection, Fresenius Kabi, 4 mg/mL, 30 mL multiple dose vial, 1 count, NDC 63323-0165-30
Reason for the Shortage
    • American Regent is not marketing dexamethasone sodium phosphate injection at this time.
    • Eugia has dexamethasone injection on shortage due to increased demand.
    • Fresenius Kabi has dexamethasone sodium phosphate on shortage due to increased demand.
    • Viatris has dexamethasone injection available.
    • Hikma has dexamethasone injection available.
    • Somerset Therapeutics has 10 mg/mL 1 mL and 10 mL vials available.
Available Products
    • Dexamethasone Sodium Phosphate injection, Fresenius Kabi, 10 mg/mL, 1 mL prefilled syringe, 24 count, NDC 76045-0109-10
    • Dexamethasone Sodium Phosphate injection, Fresenius Kabi, 10 mg/mL, 1 mL preservative-free single dose vial, 25 count, NDC 63323-0506-01
    • Dexamethasone Sodium Phosphate injection, Fresenius Kabi, 4 mg/mL, 1 mL prefilled syringe, 24 count, NDC 76045-0106-10
    • Dexamethasone Sodium Phosphate injection, Fresenius Kabi, 4 mg/mL, 1 mL single dose vial, 25 count, NDC 63323-0165-01
    • Dexamethasone Sodium Phosphate injection, Fresenius Kabi, 4 mg/mL, 5 mL multiple dose vial, 25 count, NDC 63323-0165-05
    • Dexamethasone Sodium Phosphate injection, Hikma, 10 mg/mL, 1 mL vial, 25 count, NDC 00641-0367-25
    • Dexamethasone Sodium Phosphate injection, Hikma, 4 mg/mL, 1 mL vial, 25 count, NDC 00641-6145-25
    • Dexamethasone Sodium Phosphate injection, Hikma, 4 mg/mL, 5 mL vial, 10 count, NDC 00641-6146-10
    • Dexamethasone Sodium Phosphate injection, Mylan Institutional (Viatris), 10 mg/mL, 10 mL vial, 10 count, NDC 67457-0420-10
    • Dexamethasone Sodium Phosphate injection, Mylan Institutional (Viatris), 4 mg/mL, 1 mL vial, 25 count, NDC 67457-0423-12
    • Dexamethasone Sodium Phosphate injection, Mylan Institutional (Viatris), 4 mg/mL, 30 mL vial, 25 count, NDC 67457-0421-30
    • Dexamethasone Sodium Phosphate injection, Mylan Institutional (Viatris), 4 mg/mL, 5 mL vial, 25 count, NDC 67457-0422-54
    • Dexamethasone Sodium Phosphate injection, Somerset Therapeutics LLC, 10 mg/mL, 1 mL preservative-free vial, 25 count, NDC 70069-0021-25
    • Dexamethasone Sodium Phosphate injection, Somerset Therapeutics LLC, 10 mg/mL, 10 mL multiple dose vial, 10 count, NDC 70069-0025-10

Estimated Resupply Dates

    • Eugia has dexamethasone sodium phosphate 10 mg/mL 1 mL preservative-free vials, 10 mg/mL 10 mL vials, and 4 mg/mL 30 mL vials on intermittent back order and the company is releasing product as it becomes available.
    • Fresenius Kabi has dexamethasone sodium phosphate 10 mg/mL 10 mL vials on back order and the company estimates a release date of early-May 2024. There are short-dated 4 mg/mL 30 mL vials available with an expiration date of < 8 months.

Updated

Updated April 23, 2024 by Michelle Wheeler, PharmD, Drug Information Specialist. Created March 18, 2011 by Jane Chandramouli, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer